Background: Despite good immediate and long-term results, post procedural deterioration of the renal function (RF) may occur after Renal Artery Angioplasty and Stenting (RAAS) in 20-40 % of the patients, which limits the immediate benefits of the technique. Atheroembolism seems to play an important role. We evaluate feasibility and safety of RAAS utilizing a distal protection device (DPD) to reduce the risk of atheroembolism and avoid deteriorations of the RF. Methods: 171 RAAS performed under DPD in 151 hypertensive patients (M:102). Mean age: 65.2 AE 10.8 yrs with atherosclerotic renal artery stenosis (20 bilateral). 11 pts had solitary kidneys, 62 renal insufficiencies. We used occlusion balloon (n ¼ 46) or filters (n ¼ 125). We recently experimented and treated 12 patients with a new filter the Fibernet (Lumen Biomedical Plymouth MN) which can capture particles of 40m without compromising the flow. Generated debris removed and analyzed. Blood pressure and serum creatinine levels followed. Techniques of RAAS under protection, limitations will be discussed. Results: Immediate technical success: 100 %. Visible debris aspirated with Percusurge from all patients. Mean particle number: 98.1 AE 60.00. Mean diameter: 201.2 AE 76m (38-6206). With current filters debris were removed in 80 % of the cases. With the Fibernet visible debris were removed in all cases. Mean debris surface area: 121mm 2 . Mean number of particles 28-60m : 2136 AE 776, >60m. We observed one acute RF deterioration. Mean follow-up: 32.2 AE 17 months. Mean creatinine level remains constant during follow-up. At 6 months (131 patients) 95 patients stabilized, 35 with baseline renal insufficiency improved and we had only one RF deterioration (1 %) in a patient with moderate renal insufficiency. At 2 years (105 patients) 73 stabilized, 28 improved and we only had 4 RF deterioration (4 %). Conclusions: This study demonstrates the feasibility and safety of DPD during renal interventions to protect against atheroembolism and seems to avoid RF deterioration after the procedure and in the long-term. Indications will be discussed. Improvements in DPD for renal stenting are mandatory. Randomized studies are awaited.
Background: Despite good immediate and long-term results, post procedural deterioration of the renal function (RF) may occur after Renal Artery Angioplasty and Stenting (RAAS) in 20-40 % of the patients, which limits the immediate benefits of the technique. Atheroembolism seems to play an important role. We evaluate feasibility and safety of RAAS utilizing a distal protection device (DPD) to reduce the risk of atheroembolism and avoid deteriorations of the RF. Methods: 171 RAAS performed under DPD in 151 hypertensive patients (M:102). Mean age: 65.2 AE 10.8 yrs with atherosclerotic renal artery stenosis (20 bilateral). 11 pts had solitary kidneys, 62 renal insufficiencies. We used occlusion balloon (n ¼ 46) or filters (n ¼ 125). We recently experimented and treated 12 patients with a new filter the Fibernet (Lumen Biomedical Plymouth MN) which can capture particles of 40m without compromising the flow. Generated debris removed and analyzed. Blood pressure and serum creatinine levels followed. Techniques of RAAS under protection, limitations will be discussed. Results: Immediate technical success: 100 %. Visible debris aspirated with Percusurge from all patients. Mean particle number: 98.1 AE 60.00. Mean diameter: 201.2 AE 76m (38-6206). With current filters debris were removed in 80 % of the cases. With the Fibernet visible debris were removed in all cases. Mean debris surface area: 121mm 2 . Mean number of particles 28-60m : 2136 AE 776, >60m. We observed one acute RF deterioration. Mean follow-up: 32.2 AE 17 months. Mean creatinine level remains constant during follow-up. At 6 months (131 patients) 95 patients stabilized, 35 with baseline renal insufficiency improved and we had only one RF deterioration (1 %) in a patient with moderate renal insufficiency. At 2 years (105 patients) 73 stabilized, 28 improved and we only had 4 RF deterioration (4 %). Conclusions: This study demonstrates the feasibility and safety of DPD during renal interventions to protect against atheroembolism and seems to avoid RF deterioration after the procedure and in the long-term. Indications will be discussed. Improvements in DPD for renal stenting are mandatory. Randomized studies are awaited.
Peripheral Vascular: Miscellaneous and Other
Washington Convention Center, Lower Level, Hall A Saturday, September 13, 2014, 5:00 PM-7:00 PM Background: In patients with massive pulmonary embolism the treatment choices are systemic fibrinolysis and surgical embolectomy as both methods are proved to reverse right ventricular failure and cardiogenic shock. In one third of patients systemic fibrinolysis is contraindicated and surgical treatment is high risk and not widely available. A feasible alternative of those treatments are percutaneous catheter technics. Methods: All 20 patients were with PE and hemodynamic instability defined as a systolic arterial pressure 90 mm Hg or drop of systolic pressure of ! 40 mm Hg for over 15 min or need for catecholamine administration, and echocardiographic evidence for RV dysfunction. We used right or left common femoral vein for access site with insertion of 8 Fr sheath. Hemodynamic assessment was obtained before and at the end of the procedure. After insertion of 5 Fr Pigtail catheter consecutively in the right and left main branch a local administration of alteplase 25 mg was performed through the Pigtail catheter. With 0.035 inch guidwire through the pigtail a rotational thrombus fragmentation was performed. After the catheter directed thrombolysis and rotational thrombus fragmentation a precise selective angiography was made with a 8 Fr guiding catheter JR in all segmental branches of the pulmonary artery with diameter above 6 mm. A meticulous thrombus aspiration was then performed in all segmental branches that were involved through the same catheter. Results: From the analyzed 20 patients 63% were male with a mean age of 54 years. The in-hospital survival was 92.7% as only one patients died due to lung infection. In 24 hours after the procedure there was an increase in both O2 saturation (91,5% vs 96,27%, p< 0.001) and pO2(66,4 vs. 96,5 mm Hg, p< 0.001). The right ventricular basal diameter decreased (48 mm vs. 38 mm, p< 0.001) and TAPCE was increased (13 mm vs. 20 mm p¼0.001). The systolic (70 mmHg vs. 51 mmHg p¼0.03) and mean (45 mmHg vs. 34 mmHg, p¼0.001) pulmonary artery pressure also decreased. At 6 months follow-up all patients were alive with NYHA II class heart failure. Conclusions: The described technique is effective and save method for treatment of high risk patients with PE.
TCT-511
Catheter directed thrombolysis and mechanical thrombectomy pulmonary embolism Background: Percutaneous thrombectomy and catheter directed thrombolysis (CDT) represent well established techniques for treatment of submassive pulmonary embolism (SPE). The purpose of CDT is to dissolve thrombus and to restore the lumen without causing distal embolization as fast as possible. Methods: We have enrolled in 2011-2013 our patients with SPE in a prospective register and we have analysed our patients clinical, interventional and echocardiographic data. We have examined the efficacy and safety of CDT in the treatment of SPE. The access site for SPE was the femoral. Caval filters were implanted from jugular or from femoral veins. After the sheath advancement, occlusions were passed with a 0.035 guidewire and CDT was started with Alteplase over a pig tail catheter for 12-24 hours. After 24 hours, control pulmonary angiography was performed and the CDT was maintained when the thrombus burden was flow limiting or the pulmonary pressure has not decreased with 50%. When the CDT was not successful, manual thrombectomy and thrombus fragmentation was performed with a 7F guiding and pig tail catheter. Postoperatively, patients were treated with systemic anticoagulation, compression hose, and interval follow-up. Results: 26 patients were treated with a mean age of 52.5AE14.9 years. CDT was successful after the first post-operative day in 19 patients (73%) but in 7 patients (27%) thrombus aspiration and thrombectomy was performed after failed thrombolysis. In two patients (7.2%) caval filters were implanted. Good angiographic and clinical outcome was achieved in 25 patients (96.15%). The invasive pulmonary pressure has dropped from 60. . Pre-procedure Shock Index (heart rate/systolic arterial pressure) and pulmonary systolic pressure pre and post procedure were obtained. Miller score was estimated after pulmonary angiogram was performed. Primary endpoint was in-hospital death and any bleeding. During follow-up an US was done at 3 months after discharge to assess right ventricular function and pulmonary pressures. Long term follow-up was done to assess heart failure or functional class. Results: Mean age was 64.5 +/-14.3 years, 64.3% were male, with BMI >30¼71.4%, previous malignant neoplasia in 14.2%, chronic obstructive pulmonary disease¼9.1% and immobility¼71.4%. Pre-procedure shock index was 1.43+/-0.23. After procedure Miller Score and systolic pulmonary pressures improved significantly (p< 0.001 for both). After PRT and before 30 days one patient died and no bleeding was reported. During 25.7 +/-21 months of follow-up global mortality was 28.5% (none cardiac related) and 2 pts showed evidence of mild cor pulmonale. Conclusions: Percutaneous Pulmonary Rheolytic thrombectomy was safe and effective for the treatment of these high risk patients. Long-term outcome was related to the underlying pathology.
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Ultrasound Background: There are limited therapuetic options for high risk patients with massive or sub-massive pulmonary embolism. The use of ultrasound-assisted catheter directed thrombolysis(UA-CDT) has shown to be particularly promising in various small studies. We aimed to conduct a meta-analysis of the available published studies. Methods: An extensive time unlimited literature search using MEDLINE, EMBASE & Cochrane databases using MeSH key words 'pulmonary embolism', 'ultrasound' and 'catheter-directed' identified 7 studies including a total of 240 patients. Of these 197 patients underwent use of Ekosonic catheter directed thrombolytic therapy (UCDT) for massive or sub-massive PE. Hemodynamic measures including mean & systolic pulmonary artery pressure, RV-LV ratio, heart rate and cardiac index were assessed before and after therapy. Meta-analysis was performed using Cochrane Collaboration Review Manager(version 5.1). Effect size was estimated using random effects model and mean difference with 95% confidence intervals were calculated. Results: One hundred and thirty patients were treated with UCDT. Massive & bilateral PE was reported in 74(30.8%) & 152(63.3%) patients respectively. UCDT resulted in a significant reduction in PA systolic (mean -15.22mmHg;95% CI -21.01-9.43) & mean PA pressures(mean -9.35mmHg;95% CI -13.03--5.68), in addition to a 24% increase in cardiac index. The RV size, assessed by the ratio of RV to LV dimensions, was reduced with UCDT(mean -0.35;95% CI -0.42--0.28), & the heart rate decreased by 16.9 beats/min (95% CI -26.46 --7.34). The Miller pulmonary artery occlusion score (in 87 patients)showed a significant reduction of 10.12 points (95% CI -12.21 --8.02). Thirty & 90-day all-cause mortality was 3.1% (6/197)& 4.6%(7/152) respectively with UCDT. Recurrent events & major bleeding was reported in 2/ 115(1.7%) & 7 patients(3.5%)respectively. Conclusions: In this largest meta-analysis to-date evaluating the impact of UCDT on massive & sub-massive PE, UCDT is associated with significant improvements in hemodynamic measures of RV & LV function. The procedure appears to be safe & is associated with low 30 & 90-day mortality compared to RIETE(8.65%) and ICOPER registries(17.4%). Only 92 occlusions were recanalized (82 %). Four periprocedural events occurred (1.2 %), 1 major (fatal stroke), 1 T.I.A., 2 arterial thromboses. During the follow-up (mean follow-up: 75.7 months AE 38.5), we had 40 restenoses (10 %). 13 occurred following angioplasty alone (18.8 %) and 27 following angioplasty and stent implantation (7.8 %) (P< 0.01). 10 were treated by new angioplasty alone, 30 by repeat stent implantation. Primary (PI) and secondary (PII) patencies on an intention to treat basis at 10-year followup were 80.2 % and 86.5 % respectively. In patients without initial stent placement, the rates were 67.5 % and 75.5 % while in those with stents, the rates rose to 91.5 % and 98.2 % (P < 0.01). PI for all recanalized lesions were 85.8 %, 79.1 % without stent, 91.8 % with stent (P < 0.04) and PII 92.8 %, 88.5 %, 98.1% respectively (P < 0.02). Conclusions: P.T.A. is currently the treatment of choice for subclavian artery lesions. It is a safe and effective procedure associated with low risks and good long-term results. Stents seem to limit the restenosis rate and improve long-term results. Background: Erectile Dysfunction (E D) is an important and growing health problem. It is estimated that more than 200 million men (between the age of 40 -70 years) suffer from ED . The real prevalence could be much higher as it is under reported and under treated. Out of the many etiologies, 80 % of cases are because of vasculogenic origin. Venous leak and Arterial Inflow problems (usually pudendal artery stenosis) are the most common etiologies. In patients who fail PDE -5 inhibitors therapy (Complex ED), vasculogenic causes should be strongly suspected. Methods: The workup is done by excluding the endocrinal, urological and psychological causes and then subjecting these patients to a penile Doppler study (after intra cavernosal injection of papaverine). In patients where the peak systolic penile velocity is less than 25 cm /sec, pudendal artery stenosis is strongly suspected. These patients then undergo a selective angiography for identification of pudendal artery stenosis. If the stenosis is found they are subjected to super selective pudendal artery cannulation and angioplasty or stenting using drug eluting balloon (DEB) or zatrolimus eluting stents (DES). Patients are followed up at 3, 9, 12 months and then after every year by Duplex scans. Results: 36 consecutive worked up patients of complex ED with pudendal artery stenosis underwent pudendal artery angioplasty (with DEB or DES). The procedure was successful in all patients There were no death, perineal or penile gangrene. The mean penile velocity increased from base line of 16 cm / sec to 44 ,50,58 cm /sec at 3, 6, 12 months respectively. Improvement > 4 points in International Index of Erectile Functions (IIEF -6 ) score at 3 , 6 and 12 months were 68 % , 75 % and 78 % respectively. Conclusions: Angioplasty of focal stenosis of internal pudendal artery by DEB or DES appears to be a very promising therapy for male erectile dysfunction. It is safe, feasible and leads to sustained improvement of male erectile dysfunction in about 75 % of carefully selected cases. However still many cases are ineligible for this procedure . Larger studies are required to be able to accept it as a standard therapy to treat male Erectile Dysfunction. 
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